# Testolactone for the Treatment of Girls With LHRH Resistant Precocious Puberty

> **NCT00001181** · PHASE2 · COMPLETED · sponsor: **Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)** · enrollment: 100 (—)

## Conditions studied

- Polyostotic Fibrous Dysplasia
- Precocious Puberty

## Interventions

- **DRUG:** Testolactone

## Key facts

- **NCT ID:** NCT00001181
- **Lead sponsor:** Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1982-10
- **Primary completion:** —
- **Final completion:** 2003-05
- **Target enrollment:** 100 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001181, "Testolactone for the Treatment of Girls With LHRH Resistant Precocious Puberty". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00001181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*